Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis
Andrew Wu, Ryan Yen, Sarah Grasedieck, Hanyang Lin, Helen Nakamoto, Donna L. Forrest, Connie J. Eaves, Xiaoyan Jiang
Topics & Concepts
ImatinibMedicineImatinib mesylateMyeloid leukemiaOncologyInternal medicineReceiver operating characteristicProportional hazards modelTyrosine-kinase inhibitorBiomarkermicroRNAHazard ratioBioinformaticsCancerBiologyBiochemistryGeneConfidence intervalChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchGastrointestinal Tumor Research and Treatment